Date Filed | Type | Description |
02/16/2010 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
07/10/2009 |
SC 13G/A
| WELLINGTON MANAGEMENT CO LLP reports a 4.9% stake in Cougar Biotechnology, Inc. |
07/10/2009 |
25-NSE
| Form 25-NSE -- |
07/09/2009 |
8-K
| Quarterly results |
07/07/2009 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in Cougar Biotechnology, Inc. |
07/06/2009 |
SC TO-T/A
| Form SC TO-T/A -- Tender offer statement by Third Party [amend] |
06/30/2009 |
SC 13D
| GAMCO INVESTORS, INC. ET AL reports a 3.5% stake in Cougar Biotechnology, Inc. |
06/23/2009 |
SC TO-T/A
| Form SC TO-T/A -- Tender offer statement by Third Party [amend] |
06/10/2009 |
SC 13D/A
| HORIZON BIOMEDICAL VENTURES LLC has filed a Schedule 13D for COUGAR BIOTECHNOLOGY, INC. |
06/05/2009 |
SC TO-T
| Form SC TO-T -- Tender offer statement by Third Party |
06/02/2009 |
SC 13D/A
| ROSENWALD LINDSAY A MD has filed a Schedule 13D for COUGAR BIOTECHNOLOGY, INC. |
06/01/2009 |
SC 13G
| Form SC 13G -- Statement of acquisition of beneficial ownership by individuals |
06/01/2009 |
8-K
| Other Events, Financial Statements and Exhibits |
05/29/2009 |
SC 13D
| Form SC 13D -- General statement of acquisition of beneficial ownership |
05/27/2009 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs:
|
"Form of Indemnification Agreement, substantially in the form entered into by and between Cougar Biotechnology, Inc., and each of its directors and officers and one other member of senior management of Cougar Biotechnology, Inc",
"Amended and Restated Employment Agreement, by and between Cougar Biotechnology, Inc., and Alan H. Auerbach",
"Retention Letter Agreement, by and between Johnson & Johnson, Cougar Biotechnology, Inc., and Alan H. Auerbach",
"First Amendment to Employment Letter, by and between Cougar Biotechnology, Inc., and Charles R. Eyler",
"Cougar Biotechnology, Inc. Severance Plan",
"Cougar Biotechnology, Inc. Transaction Incentive Bonus Plan" |
|
05/11/2009 |
10-Q
| Quarterly Report for the period ended March 31, 2009 |
05/11/2009 |
8-K
| Form 8-K -- Current report |
04/30/2009 |
10-K/A
| Annual Report for the period ended December 31, 2008 [amend] |
04/29/2009 |
8-K
| Form 8-K -- Current report |
03/16/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
03/16/2009 |
8-K
| Form 8-K -- Current report |
03/04/2009 |
8-K
| Form 8-K -- Current report |
02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
02/17/2009 |
SC 13G
| WELLINGTON MANAGEMENT CO LLP reports a 9.8% stake in Cougar Biotechnology, Inc. |
02/13/2009 |
SC 13G/A
| Capital World Investors reports a 4.3% stake in Cougar Biotechnology Inc |
02/12/2009 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 9.1% stake in COUGAR BIOTECHNOLOGY INC |
02/10/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
02/10/2009 |
8-K
| Form 8-K -- Current report |
11/20/2008 |
8-K
| Form 8-K -- Current report |
11/10/2008 |
10-Q
| Quarterly Report for the period ended September 30, 2008 |
11/10/2008 |
8-K
| Quarterly results |
11/03/2008 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ... |
09/30/2008 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
09/26/2008 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ... |
|